1255 — TATA Health International Holdings Balance Sheet
0.000.00%
Consumer CyclicalsHighly SpeculativeMicro Cap
Annual balance sheet for TATA Health International Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | HKAS | HKAS | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 48.5 | 47 | 33.6 | 40 | 23 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 15.5 | 16.2 | 8.79 | 62.3 | 53.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 123 | 112 | 100 | 137 | 112 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 21.9 | 10.9 | 22.4 | 27.8 | 12.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 161 | 177 | 176 | 182 | 135 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 101 | 150 | 148 | 183 | 183 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 151 | 154 | 142 | 180 | 200 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 10.1 | 23 | 33.6 | 1.72 | -64.4 |
| Total Liabilities & Shareholders' Equity | 161 | 177 | 176 | 182 | 135 |
| Total Common Shares Outstanding |